Relevant bibliographies by topics / Lateral lymph node dissection

Academic literature on the topic 'Lateral lymph node dissection'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lateral lymph node dissection.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lateral lymph node dissection"

1

Wu, Xin, Binglu Li, Chaoji Zheng, Wei Liu, Tao Hong, and Xiaodong He. "Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma." Technology in Cancer Research & Treatment 19 (January 1, 2020): 153303382096208. http://dx.doi.org/10.1177/1533033820962089.

Full text
Abstract:
Purpose: Medullary thyroid carcinoma is a rare endocrine malignancy; 75% of patients with this disease have sporadic medullary thyroid carcinoma. While surgery is the only curative treatment, the benefit of prophylactic lateral neck dissection is unclear. This study aimed to analyze the clinicopathological risk factors associated with lateral lymph node metastases and determine the indication for prophylactic lateral neck dissection in patients with sporadic medullary thyroid carcinoma. Methods: The medical records of patients with medullary thyroid carcinoma who were treated at our hospital between January 2002 and January 2020 were retrospectively reviewed; a database of their demographic characteristics, test results, and pathological information was constructed. The relationship between lateral lymph node metastases and clinicopathologic sporadic medullary thyroid carcinoma features were analyzed using univariate and multivariate analyses. Results: Overall, 125 patients with sporadic medullary thyroid carcinoma were included; 47.2% and 39.2% had confirmed central and lateral lymph node metastases, respectively. Univariate and multivariate analyses identified 2 independent factors associated with lateral lymph node metastases: positive central lymph node metastases (odds ratio = 9.764, 95% confidence interval: 2.610–36.523; p = 0.001) and positive lateral lymph nodes on ultrasonography (odds ratio = 101.747, 95% confidence interval: 14.666–705.869; p < 0.001). Conclusion: Medullary thyroid carcinoma is a rare endocrine malignancy. Lymph node metastases are common in patients with sporadic medullary thyroid carcinoma. Prophylactic lateral neck dissection is recommended for patients who exhibit positive central lymph node metastases and/or positive lateral lymph nodes on ultrasonography.
APA, Harvard, Vancouver, ISO, and other styles
2

Ozawa, Heita, Hiroki Nakanishi, Junichi Sakamoto, Yoshiyuki Suzuki, and Shin Fujita. "Prognostic impact of the number of lateral pelvic lymph node metastases on rectal cancer." Japanese Journal of Clinical Oncology 50, no. 11 (July 20, 2020): 1254–60. http://dx.doi.org/10.1093/jjco/hyaa122.

Full text
Abstract:
Abstract Background This study aimed to clarify the number of lateral pelvic lymph node metastases of colorectal cancer for which prognosis could be improved by dissection. Methods We analysed the data of 30 patients with lateral pelvic lymph node metastases of rectal cancer that underwent a total mesorectal excision with lateral pelvic lymph node dissection at our institute from 1986 to 2016. We performed survival analysis on the number of lateral pelvic lymph node metastases in each of these patients and identified an optimal cut-off point of the number of lateral pelvic lymph node metastases that would predict recurrence-free survival using the receiver operating characteristic curves and an Akaike information criterion value. Results The 5-year recurrence-free survival and overall survival of patients with one or two lateral pelvic lymph node metastases were significantly better than that of those with three or more (5-year recurrence-free survival, 63.3 vs. 0.0%, respectively; hazard ratio, 0.23; 95% CI, 0.07–0.72; P = 0.0124) (5-year overall survival, 68.2 vs. 15.6%, respectively; hazard ratio, 0.29; 95% CI, 0.09–0.92; P = 0.0300). All of the metastatic lateral pelvic lymph nodes in the group with one or two lateral pelvic lymph node metastases were restricted to the internal iliac artery or obturator nerve regions. Conclusions The cut-off number of lateral pelvic lymph node metastases in the internal iliac artery or obturator nerve regions of colorectal cancer cases in whom prognosis was improved by lateral pelvic lymph node dissection was 2; patients who had &lt;3 lateral pelvic lymph node metastases had better prognoses than those with ≥3 lateral pelvic lymph node metastases.
APA, Harvard, Vancouver, ISO, and other styles
3

Morohashi, Hajime, Yoshiyuki Sakamoto, Takuya Miura, Daichi Ichinohe, Kotaro Umemura, Takanobu Akaishi, Kentaro Sato, et al. "Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type." International Journal of Colorectal Disease 36, no. 6 (February 1, 2021): 1251–61. http://dx.doi.org/10.1007/s00384-021-03870-5.

Full text
Abstract:
Abstract Purpose There are no reports showing the significance and effective range of dissection for patients with lateral lymph node metastasis (LLNM). This study aimed to investigate the indications for lateral lymph node dissection (LLND) in patients with LLNM based on prognostic factors and recurrence types. Methods We reviewed 379 patients with advanced rectal cancer who were treated with total mesorectal excision plus LLND. We analyzed background factors and survival times of patients who had LLNM to determine prognostic factors and recurrence types. Results Pathological LLNM occurred in 44 (11.6%). Among patients with LLNM, the predictors of poor prognoses, according to univariate analysis, were > 3 node metastases, the presence of node metastasis on both sides, and spreading beyond the internal iliac lymph nodes. Moreover, LLNM beyond the internal iliac region was found to be an independent prognostic risk factor. Twenty-eight of the 44 patients with lateral lymph node metastasis (64%) relapsed, 22 of whom had distant metastases and 11 of whom experienced local recurrences. Among the latter group, nine (20%) and two (5%) had recurrences in the central and lateral pelvis, respectively. Conclusion The therapeutic benefit of resection was high, especially in patients with ≤ 3 positive lateral lymph nodes, one-sided bilateral lymph node areas, and positive nodes localized near the internal iliac artery.
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Yifan, Shuo Chen, Xiaoying Lin, Xiangqing Huang, Xiaofang Yu, and Juying Chen. "Clinical Analysis of Cervical Lymph Node Metastasis Risk Factors and the Feasibility of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma." International Journal of Endocrinology 2021 (January 31, 2021): 1–8. http://dx.doi.org/10.1155/2021/6635686.

Full text
Abstract:
Objective. To identify the risk factors for cervical lymph node metastasis (CLNM) and the feasibility of prophylactic central lymph node dissection. Methods. The characteristics of 1107 patients were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with lymph node metastasis. The relationship between the central lymph node dissection (CLND) and lateral lymph node metastasis (LLNM) was analyzed using the correlation analysis. Results. The probability of CLNM was closely related to the male gender, age <55, and the increase of tumor size. Those patients with an increase in tumor size and CLNM were extremely prone to LLNM. Also, LLNM was more likely to happen in those with the more positive central lymph nodes. Routine prophylactic central lymph node dissection (P-CLND) did not increase the risk of complications. Conclusion. P-CLND should be considered as a reasonable surgical treatment for PTC.
APA, Harvard, Vancouver, ISO, and other styles
5

Ogura, Atsushi, Stefan van Oostendorp, and Miranda Kusters. "Neoadjuvant (chemo)radiotherapy and Lateral Node Dissection: Is It Mutually Exclusive?" Clinics in Colon and Rectal Surgery 33, no. 06 (September 22, 2020): 355–60. http://dx.doi.org/10.1055/s-0040-1714239.

Full text
Abstract:
AbstractThe importance of total mesorectal excision (TME) has been the global standard of care in patients with rectal cancer. However, there is no universal strategy for lateral lymph nodes (LLN). The treatment of the lateral compartment remains controversial and has gone to the opposite directions between Eastern and Western countries in the past decades. In the East, mainly Japan, surgeons consider LLN metastases as regional disease and have performed TME with lateral lymph node dissection (LLND) without neoadjuvant (chemo)radiotherapy ([C]RT) in patients with clinical Stage II/III rectal cancer below the peritoneal reflection. In the West, neoadjuvant radiotherapy or has been the standard, and surgeons do not perform LLND assuming the (C)RT can sterilize most lateral lymph node metastasis (LLNM). Recent evidences show that lateral nodes are the major cause of local recurrence after (C)RT plus TME, and LLND reduces local recurrence particularly from the lateral compartment. Probably a combination of the two strategies, that is, neoadjuvant (C)RT plus LLND, would be needed to improve outcomes in patients with lateral nodal disease.
APA, Harvard, Vancouver, ISO, and other styles
6

Ubukata, Mamiko, Michio Itabashi, Shimpei Ogawa, Tomoichiro Hirosawa, Yoshiko Bamba, Sayumi Nakao, and Shingo Kameoka. "Japanese D3 lymph node dissection in low rectal cancer with inferior mesenteric lymph node and/or lateral lymph node metastases." Journal of Clinical Oncology 33, no. 3_suppl (January 20, 2015): 530. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.530.

Full text
Abstract:
530 Background: The current Japanese Classification of Colorectal Carcinoma defines inferior mesenteric lymph nodes (IMLN) and lateral lymph nodes (LLN) as regional lymph nodes in rectal cancer. It states that these lymph nodes should be dissected when performing D3 dissection for rectal cancer. However, there is currently no consensus on the significance of Japanese D3 lymph node dissection in low rectal cancer. A retrospective study involving a large number of patients was conducted. Methods: The subjects were 2,743 patients registered in the multi-institutional registry of the Japanese Society for Cancer of the Colon and Rectum. The data were analyzed for outcomes in R0 cases with IMLN and/or LLN metastasis (IMLN(+)LLN(-) or IMLN(-)LLN(+) or IMLN(+)LLN(+)). Results: In the control group, 67 patients (2.7%) were considered positive for IMLN metastasis, 181 patients (7.4%) for LLN metastasis, and 34 patients (1.4%) for IMLN + LLN metastasis. The outcomes in the R0 cases with IMLN and/or LLN metastasis were 52.8% for 5-year RFS and 63.1% for 5-year OS, which were each better than for R1+R2 cases (5-year RFS 26.2%, p<0.0001; 5-year OS 30.5%, p<0.0001). Including only those with a total of seven or more metastatic lymph nodes, the outcomes in the R0 cases with IMLN and/or LLN metastasis were 53.6% for 5-year RFS and 64.9% for 5-year OS, which did not differ significantly from those for IMLN(-)LLN(-) cases (5-year RFS 54.4%, 5-year OS 55.2%) (RFS: p=0.9718, OS: p=0.4049). Conclusions: We confirmed that cases of IMLN and/or LLN metastasis in low rectal cancer tend to have a large total number of metastatic lymph nodes, but a good outcome can be expected if curative resection can be performed. These results demonstrate the value of radical Japanese D3 lymph node dissection in low rectal cancer with IMLN and/or LLN metastasis.
APA, Harvard, Vancouver, ISO, and other styles
7

Nakamura, T., and M. Watanabe. "Lateral Lymph Node Dissection for Lower Rectal Cancer." World Journal of Surgery 37, no. 8 (May 24, 2013): 1808–13. http://dx.doi.org/10.1007/s00268-013-2072-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lim, Raymond Z. M., Juin Y. Ooi, Jih H. Tan, Henry C. L. Tan, and Seniyah M. Sikin. "Outcome of Cervical Lymph Nodes Dissection for Thyroid Cancer with Nodal Metastases: A Southeast Asian 3-Year Experience." International Journal of Surgical Oncology 2019 (February 28, 2019): 1–6. http://dx.doi.org/10.1155/2019/6109643.

Full text
Abstract:
Introduction. Therapeutic nodal dissection is still the mainstay of treatment for patients with lymph node metastases in many centres. The local data, however, on the outcome of therapeutic LND remains limited. Hence, this study aims to inform practice by presenting the outcomes of LND for thyroid cancer patients and our experience in a tertiary referral centre.Methods. This is a single-centre retrospective observational study in a Malaysian tertiary endocrine surgery referral centre. Patients who underwent total thyroidectomy with lymph node dissection between years 2013 and 2015 were included and electronic medical records over a 3-year follow-up period were reviewed. The outcomes of different lymph node dissection (LND), including central neck dissection, lateral neck dissection, or both, were compared.Results. Of the 43 subjects included, 28 (65.1%) had Stage IV cancer. Among the 43 subjects included, 8 underwent central LND, and 15 had lateral LND while the remaining 20 had dissection of both lateral and central lymph nodes. Locoregional recurrence was found in 16 (37.2%) of our subjects included, with no statistical difference between the central (2/8), lateral (7/15), and both (7/20). Postoperative hypocalcaemia occurred in 7 (16.3%) patients, and vocal cord palsy occurred in 5 (11.6%), whereas 9 patients (20.9%) required reoperation. Death occurred in 4 of our patients.Conclusion. High recurrence and reoperative rates were observed in our centre. While the routine prophylactic LND remains controversial, high risk patients may be considered for prophylactic LND. The long-term risk and benefit of prophylactic LND with individualised patient selection in the local setting deserve further studies.
APA, Harvard, Vancouver, ISO, and other styles
9

Aboelatta, Ibrahim H., Soliman A. El-Shakhs, Abd Elmieniem F. Mohammed, and Mohammed H. Milegy. "Role of pelvic lymphadenectomy in rectal cancer." International Surgery Journal 6, no. 6 (May 28, 2019): 1838. http://dx.doi.org/10.18203/2349-2902.isj20192150.

Full text
Abstract:
Background: Rectal cancer constitutes about one third of all colorectal cancer cases. Total mesorectal excision has become the gold standard in rectal cancer treatment. However total mesorectal excision does not involve any approaches for lateral pelvic lymph nodes (LPLN), which may be asource of local recurrences. Tumor containing LPLN were reported to be found in about 10%-20% of the rectal cancer patients. In japan lateral pelvic lymph node metastasis is accepted to be curable with excision.Methods: This study included 20 patients presented to Menofia Hospital for elective colorectal re sections and LPLN dissection, in the period from July 2016 to January 2019.Results: This study on 13 male (65%), 7 female (35%), all patients included in the study underwent preoperative chemoradiation according to the technique described by Marks et al. with an overall administration of 45 cGy over 5 weeks. Dissection of 180 lymph nodes was retrieved (20%) lymph nodes pathologically were positive for malignancy.Conclusions: Lateral pelvic lymph nodes dissection is an important in rectal cancer treatment.
APA, Harvard, Vancouver, ISO, and other styles
10

Graceffa, Giuseppa, Giuseppina Orlando, Gianfranco Cocorullo, Sergio Mazzola, Irene Vitale, Maria Pia Proclamà, Calogera Amato, et al. "Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound Evaluation." Journal of Clinical Medicine 10, no. 15 (July 30, 2021): 3407. http://dx.doi.org/10.3390/jcm10153407.

Full text
Abstract:
Lymph node neck metastases are frequent in papillary thyroid carcinoma (PTC). Current guidelines state, on a weak level of evidence, that level VI dissection is mandatory in the presence of latero-cervical metastases. The aim of our study is to evaluate predictive factors for the absence of level VI involvement despite the presence of metastases to the lateral cervical stations in PTC. Eighty-eight patients operated for PTC with level II–V metastases were retrospectively enrolled in the study. Demographics, thyroid function, autoimmunity, nodule size and site, cancer variant, multifocality, Bethesda and EU-TIRADS, number of central and lateral lymph nodes removed, number of positive lymph nodes and outcome were recorded. At univariate analysis, PTC location and number of positive lateral lymph nodes were risk criteria for failure to cure. ROC curves demonstrated the association of the number of positive lateral lymph nodes and failure to cure. On multivariate analysis, the protective factors were PTC located in lobe center and number of positive lateral lymph nodes < 4. Kaplan–Meier curves confirmed the absence of central lymph nodes as a positive prognostic factor. In the selected cases, Central Neck Dissection (CND) could be avoided even in the presence of positive Lateralcervical Lymph Nodes (LLN+).
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lateral lymph node dissection"

1

Hassan, Hakki. "Morbidity of mediastinal lymph node dissection VS sampling treatment of lung cancer /." Bern : [s.n.], 1999. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nini, Alessandro [Verfasser]. "The role of lymph node dissection in kidney cancer surgery for staging and therapy / Alessandro Nini." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2020. http://d-nb.info/1238074197/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Owusu, Miriam Sekyere. "Lymphedema, post breast cancer treatment at Komfo Anokye Teaching Hospital, Kumasi, Ghana." Thesis, Cape Peninsula University of Technology, 2011. http://hdl.handle.net/20.500.11838/2262.

Full text
Abstract:
Thesis (MTech (Nursing))--Cape Peninsula University of Technology, 2011.
To determine the incidence, risk factors and the treatment of lymphedema after breast cancer treatment at the oncology unit of KATH, Kumasi, Ghana from 01 January 2005 to 31 December 2008. Descriptive retrospective survey was used. Using a data capture sheet, data was collected from the medical records of the breast cancer patients. Breast cancer and lymphedema-related variables were collected. Data was analyzed as descriptive statistics. Chi-square test was applied to determine whether or not two variables are independent variables. Among 313 patients treated for breast cancer between 2005 and 2008, 31 (9.9%) developed lymphedema after treatment. A chi-square test showed that axillary lymph node dissection was statistically a significant risk factor of lymphedema (Chi-square test value=7.055, P value=0.008). Radiation and late stage of breast cancer diagnosis may have contributed in development of lymphedema despite having P value> 0.05. Age, body mass index (BMI) and hypertension were also not associated with lymphedema.
APA, Harvard, Vancouver, ISO, and other styles
4

Nishimura(Tada), Harue. "Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma." 京都大学 (Kyoto University), 2009. http://hdl.handle.net/2433/126591.

Full text
Abstract:
Kyoto University (京都大学)
0048
新制・論文博士
博士(社会健康医学)
乙第12395号
論社医博第4号
新制||社医||6(附属図書館)
27425
UT51-2009-M901
京都大学大学院医学研究科社会健康医学系専攻
(主査)教授 小西 郁生, 教授 佐藤 俊哉, 教授 鈴木 茂彦
学位規則第4条第2項該当
APA, Harvard, Vancouver, ISO, and other styles
5

Vercellino, Giuseppe F. [Verfasser]. "Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer / Giuseppe F. Vercellino." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2014. http://d-nb.info/1062949226/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vercellino, Giuseppe Filiberto [Verfasser]. "Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer / Giuseppe F. Vercellino." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2014. http://d-nb.info/1062949226/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

von, Below Catrin. "PET and MRI of Prostate Cancer." Doctoral thesis, Uppsala universitet, Radiologi, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-300940.

Full text
Abstract:
Prostate cancer (PCa) is the most common non-skin malignancy of men in developed countries. In spite of treatment with curative intent up to 30-40% of patients have disease recurrence after treatment, resulting from any combination of lymphatic, hematogenous, or contiguous local spread. The concept of early detection of PCa offer benefits in terms of reduced mortality, but at the cost of over-diagnosis and overtreatment of indolent disease. This is largely due to the random nature of conventional biopsies, with a risk of missing significant cancer and randomly hitting indolent disease. In the present thesis, diagnostic performance of MRI DWI and 11C Acetate PET/CT lymph node staging of intermediate and high risk PCa, was investigated, and additionally, predictive factors of regional lymph node metastases were evaluated. Further, additional value of targeted biopsies to conventional biopsies, for detection of clinically significant PCa, was investigated. In paper one and two, 53 and 40 patients with predominantly high risk PCa underwent 11C Acetate PET/CT and 3T MRI DWI, respectively, for lymph node staging, before extended pelvic lymph node dissection (ePLND). The sensitivity and specificity for PET/CT was 38% and 96% respectively. The sensitivity and specificity for MRI DWI was 55% and 90% respectively. In paper three, 53 patients with newly diagnosed PCa were included. All patients underwent multi-parametric MRI, followed by two cognitive targeted biopsies. Five more clinically significant cancers were detected by adding targeted biopsies to conventional biopsies. In paper four the value of quantitative and qualitative MRI DWI and 11C Acetate PET/CT parameters, alone and in combination, in predicting regional lymph node metastases were examined. ADCmean in lymph nodes and T-stage on MRI were independent predictors of lymph node metastases in multiple logistic regression analysis. In conclusion the specificity of diffusion weighted MRI and 11C Acetate PET/CT for lymph node staging was high, although the sensitivity was low. Predictive factors of regional lymph node metastases could be retrieved from diffusion weighted MRI and 11C Acetate PET/CT. By combining targeted biopsies with conventional biopsies the detection rate of clinically significant PCa could be increased.
APA, Harvard, Vancouver, ISO, and other styles
8

Matheus, Carolina Nascimben 1980. "Avaliação do fluxo sanguíneo do membro superior de mulheres submetidas a abordagem axilar para tratamento do câncer de mama : Blood flow in the superior limbs of women with breast cancer undergoing a surgical approach to the axilla." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312844.

Full text
Abstract:
Orientador: Luís Otávio Zanatta Sarian
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-27T18:24:57Z (GMT). No. of bitstreams: 1 Matheus_CarolinaNascimben_D.pdf: 2850729 bytes, checksum: fd170a425e039c6e8f1324b637393c8b (MD5) Previous issue date: 2015
Resumo: Objetivo: Esta tese visou avaliar os parâmetros vasculares arteriais e venosos dos vasos axilares e braquiais em mulheres submetidas a tratamento para câncer de mama. Subdividimos estas avaliações conforme os objetivos abordados em duas publicações, respectivamente: 1) Comparar aos parâmetros de circulação venosa e arterial nos vasos axilares e braquiais em função do tipo de abordagem cirúrgica da axila (BLS ou LAT) em até seis meses após a intervenção. 2) Identificar os fatores que influenciam os parâmetros vasculares da veias axilares e braquiais ipsilaterais à cirurgia para tratamento do câncer de mama. Métodos: Foram identificadas 547 pacientes consecutivas, submetidas a tratamento cirúrgico para câncer de mama entre agosto de 2012 e janeiro de 2014. Depois de seguir critérios de inclusão e exclusão, 197 mulheres foram recrutadas. O projeto foi aprovado pelo comitê de ética do hospital e todos os pacientes assinaram o termo de consentimento informado. Os critérios de inclusão foram 1) câncer da mama primário operável 2) abordagem axilar cirúrgica; 3) não ter sido submetida a reconstrução da mama. Os critérios de exclusão foram 1) câncer de mama bilateral, 2) história prévia de procedimentos cirúrgicos para um dos membros superiores ou no tórax, 3) comprometimento ortopédico ou neurológico de um dos membros superiores, 4) insuficiência renal ou cardíaca. Todas as pacientes responderam a um breve questionário sobre suas características clínicas e epidemiológicas. Foi então realizada avaliação ultrassonográfica dos vasos braquiais e axilares, bilateralmente, nos seguintes momentos: no dia anterior à cirurgia e 1, 3, 6 e 12 meses após a cirurgia. No primeiro artigo, comparamos os parâmetros arteriais e venosos, até seis meses após a cirurgia, em função da realização de dissecção linfática completa ou linfonodo sentinela; no segundo, restringimos as análises ao sistema venoso e estendemos a avaliação para até 1 ano após a cirurgia, comparando os parâmetros vasculares em função de características clínicas e epidemiológicas das pacientes e das modalidades de tratamentos utilizados. Resultados: Foram encontradas restrições de diâmetro em veias do braço ipsilateral ao câncer de mama de mulheres submetidas à dissecção axilar (LAT), efeito que não foi observado no grupo BLS. A área da secção transversal de veias braquial e axilar diminuiu progressivamente até seis meses, com a redução do fluxo sanguíneo concomitante destes vasos. Encontramos, na mulher sem linfedema, que a área de secção transversal e fluxo venoso do sangue (especialmente veia braquial) são negativamente afetados pela cirurgia e / ou quimioterapia / radioterapia. Este efeito prejudicial parece persistir até um ano. Não houve diferença significativa em nenhum dos parâmetros estudados entre os vasos ipsi e contralaterais ao câncer de mama. Conclusões: De maneira geral, nosso estudo demonstra que os tratamentos cirúrgicos, especialmente LAT, e a radio e quimioterapia, possuem efeitos deletérios sobre a circulação sanguínea dos vasos axilares e braquiais, sobretudo venosos. Esses efeitos são aparentemente permanentes e há necessidade de extensão do tempo de follow-up a fim de avaliar se o desenvolvimento subsequente de linfedema ocorrerá em associação às alterações vasculares
Abstract: Objective: The aim of this thesis was to evaluate the arterial and venous vascular parameters of the axillary and brachial vessels in women who underwent treatment for breast cancer. We subdivided these assessments according to the following objectives, in two publications: 1) To compare the venous and arterial vascular parameters in the axillary vessels and brachial depending on the type of axillary surgical approach (SLNB or ALND) within six months after the intervention. 2) To identify which factors influence the vascular parameters of axillary and brachial veins ipsilateral to surgical for treatment of breast cancer. Methods: We identified 547 consecutive patients undergoing surgical treatment for breast cancer between August 2012 and January 2014. After following inclusion and exclusion criteria, 197 women were recruited. The project was approved by the hospital's ethics committee and all patients signed an informed consent form. Inclusion criteria were 1) primary operable breast cancer 2) surgical axillary approach; 3) not having undergone breast reconstruction. Exclusion criteria were 1) bilateral breast cancer, 2) history of previous surgical procedures for one of the upper limbs or breast, 3) orthopedic or neurological impairment of one upper limb, 4) kidney or heart failure. All patients completed a brief questionnaire about their clinical and epidemiological characteristics. Then we performed Doppler ultrasonography evaluation of axillary and brachial vessels, bilaterally, at the following times: the day before surgery and 1, 3, 6 and 12 months after surgery. In the first article, we compared the arterial and venous parameters, up to six months after surgery, depending on SLNB or ALND; in the second, we restricted the analysis to the venous system and extend the evaluation for up to 1 year after surgery, comparing the vascular parameters with clinical and epidemiological characteristics of patients and treatment modalities used. Results: diameter restrictions were found in the ipsilateral veins of the arm in women with breast cancer undergoing ALND, and that effect was not observed in SLNB group. The cross sectional area of brachial and axillary veins progressively decreased up to six months, with concomitant reduction of blood flow to these vessels. In women with no lymphedema, the cross-sectional area and venous blood flow (especially brachial vein) are negatively affected by surgery and / or chemotherapy / radiotherapy. This detrimental effect seems to persist up to one year. There was no significant difference on studied parameters between ipsilateral and contralateral vessels to breast cancer. Conclusions: In essence, our study shows that surgical treatments, especially ALND, and the radiation and chemotherapy, have deleterious effects on blood circulation of the axillary and brachial vessels, especially venous. These effects are apparently permanent, prompting the extension of the follow-up evaluation in order to assess whether subsequent lymphedema formation will be associated with vascular abnormalities
Doutorado
Oncologia Ginecológica e Mamária
Doutora em Ciências da Saúde
APA, Harvard, Vancouver, ISO, and other styles
9

Mulla, Mubashir Ganie. "The role of cervical lymph node metastases and their dissection in papillary thyroid cancer employing different surgical approaches with regards to their long-term prognosis and outcomes." Thesis, King's College London (University of London), 2017. https://kclpure.kcl.ac.uk/portal/en/theses/the-role-of-cervical-lymph-node-metastases-and-their-dissection-in-papillary-thyroid-cancer-employing-different-surgical-approaches-with-regards-to-their-longterm-prognosis-and-outcomes(070ff73f-7963-4b96-a085-8f22d8da8c73).html.

Full text
Abstract:
Background: Papillary Thyroid Cancer (PTC) is a common endocrine cancer which metastases to the cervical lymph nodes (LN). The frequency of metastasis is poorly defined. The imaging modalities commonly employed to detect these metastases have limitations. The aim of this study was to define the extent of cervical LN metastases, the role of imaging in their detection and to determine long term outcomes. Design and Methods: The study was designed in two parts. A. Systematic reviews of incidence of cervical LN metastases in PTC and the use of imaging modalities in detection of these LN. B. Retrospective Cohort Study of PTC patients: Data from three centres in London over the last 9 years was collected and analysed. Results: I. Systematic reviews: A. Central LN Dissection (LND): 21 studies provided data for 4188 patients. Among patients who underwent prophylactic central LND (pCLND), 772 had positive central LN (44.8 %). B. Lateral LND: 19 studies provided data for 5587 patients. Out of 2048 patients who underwent pLLND, 1177 were found to have positive lateral LNs (57.5%). C. Imaging of metastatic cervical LN Ultrasound: The sensitivity to detect central and lateral cervical LN was 38.4% and 27.2% respectively. Computerised Tomography: The sensitivity to detect central LN was 67%. For lateral LN none of the studies calculated the sensitivity accurately. II. Results from the Cohort Study 44 patients were included in the analyses. 53.8% had positive LN when pLLND dissection was performed. Recurrence free survival between the two cohorts was not statistically significant. Overall survival was 100% for both groups. Conclusions: Prophylactic LND yielded metastatic central and lateral LN in about half of all patients with PTC. Imaging modalities currently utilised for detection of metastatic central and lateral cervical LN have low sensitivities. In our cohort of patients, prophylactic lateral lymph node dissection did not show any significant difference in terms of long term outcomes.
APA, Harvard, Vancouver, ISO, and other styles
10

Quadros, Claudio de Almeida. "Linfonodectomia retroperitoneal e pélvica lateral guiada por radiotraçador e azul patente no estadiamento do adenocarcinoma do reto." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5132/tde-09122009-152351/.

Full text
Abstract:
INTRODUÇÃO: A excisão total do mesorreto é o procedimento cirúrgico padrão para o tratamento do adenocarcinoma do reto. Resultados satisfatórios, em termos de prognóstico, alcançados com a associação da linfonodectomia retroperitoneal e pélvica lateral questionam se somente a excisão total do mesorreto seria suficiente para um estadiamento adequado, podendo afetar decisões relacionadas ao tratamento adjuvante. Este estudo avaliou o impacto das metástases em linfonodos retroperitoneais e/ou pélvicos laterais na mudança do estadiamento de pacientes com adenocarcinoma do reto e a acurácia da identificação de metástases em linfonodos das cadeias retroperitoneais e/ou pélvicas laterais com o uso de tecnécio-99m-fitato e/ou azul patente. MÉTODOS: Foi realizado estudo prospectivo de janeiro de 2004 a agosto de 2008, composto por 97 pacientes com adenocarcinoma do reto extraperitoneal submetidos a tratamento cirúrgico curativo com excisão total do mesorreto e linfonodectomia retroperitoneal e pélvica lateral, com pesquisa de linfonodos das cadeias retroperitoneais e pélvicas laterais identificados com tecnécio-99m-fitato e/ou corados em azul patente. Os linfonodos radioativos e/ou azuis, quando negativos ao exame histopatológico com hematoxilina-eosina, foram submetidos à multisecções histológicas com uso de técnicas imunohistoquímicas com anticorpos anticitoqueratinas (AE1/AE3). RESULTADOS: A média de linfonodos nas peças de excisão total do mesorreto foi de 11,5 (1119/97) e nas cadeias retroperitoneais e pélvicas laterais foi de 11,7 (1136/97). A linfonodectomia retroperitoneal e pélvica lateral identificou metástases em 17,5% dos pacientes do estudo e promoveu aumento do estádio TNM II para III em 8,2% dos pacientes. As variáveis relacionadas à presença de linfonodos retroperitoneais e/ou pélvicos laterais metastáticos foram o estádio III estabelecido na peça cirúrgica da excisão total do mesorreto (P < 0,04); a classificação pT3/pT4 do tumor primário (P = 0,047); níveis elevados de antígeno carcinoembrionário, com média de 30,6 ng/ml e mediana de 9,9 ng/ml (P = 0,014); e grandes tumores, com tamanho médio de 5,5 ± 3,2 cm (P = 0,03). A migração do tecnécio e/ou azul patente para linfonodos retroperitoneais e/ou pélvicos laterais ocorreu em 37,1% (36/97), modificando o estadiamento em 11,1% dos pacientes estudados. A acurácia do uso do tecnécio e/ou azul patente na detecção de metástases nos linfonodos retroperitoneais e pélvicos laterais foi de 100%, com sensibilidade de 100%, valor preditivo negativo de 100% e zero de falso-negativos. CONCLUSÕES: Deve-se aprimorar o uso de marcadores na identificação de metástases para indicação seletiva da linfonodectomia retroperitoneal e pélvica lateral em adenocarcinoma retal.
BACKGROUND: Total mesorectal excision is the standard surgical procedure for rectal adenocarcinoma treatment. Good prognostic results achieved with retroperitoneal and lateral pelvic lymphadenectomy have questioned that total mesorectal excision might not be satisfactory for adequate patient staging, affecting adjuvant therapeutic definitions. The aims of this study were to define the upstaging impact of metastasis to retroperitoneal and/or lateral pelvic nodes in patients with rectal adenocarcinoma and the accuracy of dye and/or probe search in the detection of metastatic retroperitoneal and/or lateral pelvic nodes. METHODS: A prospective study was carried on from January of 2004 to August of 2008, composed of 97 extraperitoneal rectal adenocarcinoma patients submitted to curative intent surgeries with total mesorectal excision and retroperitoneal and lateral pelvic lymphadenectomy, with retroperitoneal and lateral pelvic nodes mapping using technetium-99m-phytate and/or patent blue. The radioactive and/or blue nodes, when negative to histopathological hematoxylin-eosin staining, were submitted to step-sectioning and immunohistochemical examination with antibody against cytokeratin (AE1/AE3). RESULTS: Mean node count of the mesorectal excision specimen was 11.5 (1119/97) and of the retroperitoneal and lateral pelvic lymphadenectomy was 11.7 (1136/97). Retroperitoneal and lateral pelvic lymphadenectomy identified metastasis in 17.5% of the studied patients and modified TNM stage II to III in 8.2% of the patients. Factors related to metastatic retroperitoneal and lateral pelvic nodes were stage III defined by examination of the surgical specimen of the total mesorectal excision (P < 0,004); tumor pT3/pT4 classification (P = 0,047); high levels of carcinoembryonic antigen, with average of 30.6 ng/ml and median of 9.9 ng/ml (P = 0,014); and large tumors, with mean size of 5.5 cm ± 3,2 cm (P = 0,03). Technetium and/or patent blue migration to retroperitoneal and/or lateral pelvic nodes occurred in 37.1% (36/97), upstaging 11.1% of the studied patients. Technetium and/or patent blue accuracy in the detection of metastasis to retroperitoneal and/or lateral pelvic nodes was of 100%, with sensibility of 100%, negative predictive value of 100% and zero false negatives. CONCLUSIONS: The use of markers should be improved in the identification of metastasis for selective indication of retroperitoneal and lateral pelvic lymphadenectomy.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Lateral lymph node dissection"

1

C, Ames Frederick, ed. Groin dissection. Chicago: Year Book Medical Publishers, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kim, Nam Kyu. Robotic Intersphincteric Resection with Lymph Node Dissection for Low Rectal Cancer. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-33-6123-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Leong, Stanley P. L. Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer. Cleveland: Kluwer Academic Publishers, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

House, United States Congress. A bill to require that health plans provide coverage for a minimum hospital stay for mastectomies and lymph node dissection for the treatment of breast cancer, and coverage for secondary consultations. Washington, D.C: U.S. G.P.O., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

United States. Congress. House. A bill to require that health plans provide coverage for a minimum hospital stay for mastectomies, lumpectomies, and lymph node dissection for the treatment of breast cancer and coverage for secondary consultations. [Washington, D.C.?]: [United States Government Printing Office], 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

United States. Congress. Senate. A bill to amend the Public Health Service Act and Employee Retirement Income Security Act of 1974 to require that group and individual health insurance coverage and group health plans provide coverage for a minimum hospital stay for mastectomies and lymph node dissections performed for the treatment of breast cancer. Washington, D.C: U.S. G.P.O., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kwon, Rachel J. Sentinel Lymph Node Dissection versus Complete Axillary Dissection in Invasive Breast Cancer. Edited by Patrick Borgen and Miguel A. Burch. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199384075.003.0022.

Full text
Abstract:
This chapter provides a summary of a landmark study in breast surgical oncology: the Z0011 trial. In patients with invasive breast cancer and positive sentinel lymph nodes, does complete axillary lymph node dissection improve survival relative to sentinel node dissection alone? Starting with that question, it describes the basics of the study, including funding, year study began, year study was published, study location, who was studied, who was excluded, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, gives a summary and discusses implications, and concludes with a relevant clinical case involving axillary dissection versus sentinel lymph node biopsy only.
APA, Harvard, Vancouver, ISO, and other styles
8

Hoskin, Peter. Vulva and vagina. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0014.

Full text
Abstract:
Chapter 9b discusses carcinoma of the vulva, which is primarily a surgical disease best treated by wide surgical resection, radical vulvectomy, and inguinal lymph node dissection based on presenting stage. Rarely, locally advanced primary disease may be presented for primary radiotherapy treatment. Postoperative radiotherapy is recommended for tumours invading >7 mm in a vertical direction. The first station regional lymph nodes in the inguinal region are best treated by radical surgical dissection, but fixed inoperable lymph nodes may benefit from primary radiotherapy which may be followed where appropriate by surgery if there is a residual mass. Postoperative radiotherapy should be considered for women having more than one node involved with metastatic tumour at surgery. This must be balanced against the increased risk of lymphoedema where both surgery and radiotherapy are delivered to the groins. Chemoradiation using cisplatin or 5-FU/mitomycin C-based schedules has been reported but no randomized comparison with radiotherapy alone has been undertaken; whilst high response rates are seen there is a considerable increase in acute toxicity.
APA, Harvard, Vancouver, ISO, and other styles
9

Leong, Stanley P. L. Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer (Cancer Treatment and Research). Springer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

L, Leong Stanley P., ed. Atlas of selective sentinel lymphadenectomy for melanoma, breast cancer, and colon cancer. Boston: Kluwer Academic Publishers, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lateral lymph node dissection"

1

Konishi, Tsuyoshi. "Laparoscopic Lateral Pelvic Lymph Node Dissection." In Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract, 275–85. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18740-8_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Konishi, Tsuyoshi. "Robotic Lateral Pelvic Lymph Node Dissection." In Robotic Colorectal Surgery, 121–32. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-15198-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kobayashi, Hirotoshi, and Kenichi Sugihara. "Lateral Pelvic Lymph Node Dissection (Pelvic Sidewall Dissection)." In Springer Surgery Atlas Series, 299–316. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-60827-9_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fujita, Shin, and Kenjiro Kotake. "Lateral Lymph Node Dissection for Rectal Cancer." In Modern Management of Cancer of the Rectum, 187–97. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6609-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Liang, Jin-Tung. "Minimally Invasive Lateral Pelvic Lymph Node Dissection." In Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract, 287–94. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18740-8_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kusters, Miranda, Yoshihiro Moriya, Harm J. T. Rutten, and Cornelis J. H. van de Velde. "Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection." In Rectal Cancer, 53–78. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-567-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nagayama, Satoshi, Masashi Ueno, and Takeshi Sano. "Laparoscopic Right Lateral Pelvic Lymph Node Dissection (LPLND) with Pelvic Autonomic Nerve Preservation." In Laparoscopic Surgery for Colorectal Cancer, 137–53. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55711-1_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kagawa, Hiroyasu, and Yusuke Kinugasa. "Pelvic Autonomic Nerve Preservation and Lateral Pelvic Lymph Node Dissection: Techniques and Oncologic Benefits." In Surgical Treatment of Colorectal Cancer, 131–38. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5143-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Xishan, Zhaoxu Zheng, and Haipeng Chen. "Laparoscopic Extended Lower Rectal Cancer Resection with En Bloc Lateral Lymph Node Dissection (Wang’s Approach)." In Natural Orifice Specimen Extraction Surgery, 475–90. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-7925-7_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Toker, Alper. "Lymph Node Dissection." In Chest Surgery, 217–28. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-12044-2_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lateral lymph node dissection"

1

Sun, Zhihui, Jia Liu, Peisong Wang, Yanhua Li, Zhi Lv, Yi Han, and Guang Chen. "The Features of Lymph Node Metastasis of Differentiated Thyroid Carcinoma and the Choice of Lateral Neck Lymph Nodes Dissection." In 2016 8th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2016. http://dx.doi.org/10.1109/itme.2016.0081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pappa, C., S. Smith, HJ Jiang, and M. Alazzam. "1115 Inguinofemoral lymph node dissection technique." In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alkhan, F., E. Karabuk, MM Naki, M. Gungor, and MF Kose. "EP1347 Laparoscopic para-aortic lymph node dissection." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.1351.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mikami, Mikio. "Inguinofemoral lymph node dissection for vulvar cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.m24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

García Pineda, V., I. Zapardiel Gutiérrez, J. Siegrist Ridruejo, MD Diestro Tejeda, and A. Hernández Gutiérrez. "EP1320 How to get an excellent anatomical landmarks exposure in trasperitoneal paraaortic lymph node dissection. Systematic lymph node dissection in five steps." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.1324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kaur, Inderjit, Swarupa Mitra, Manoj Kumar Sharma, Upasna Saxena, Parveen Ahlawat, Amit Kumar Choudhary, Sarthak Tandon, and Prashant Surkar. "Case report of vaginal melanoma." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685371.

Full text
Abstract:
Primary malignant melanoma of vagina is a rare disease with a predilection for local recurrence, distant metastasis and short survival time. Due to the low incidence and lack of reporting in the literature, treatment choices still remain controversial. We describe 2 cases of vaginal malignant melanoma. A 42 yr old female presented with complaints of post coital and per vaginal bleed of 1 month duration. Examination findings show growth 6 cm x 6 cm on anterior vaginal wall, another 3 x 3 cm lesion on right lateral vaginal wall. Vaginal biopsy showed malignant melanoma, S-100 and HMB-45 positive while negative for CK and LCA. MRI Whole abdomen showed altered lesion [3.8cm (AP), 6.0cm (TR) and 4.9cm (CC)] in upper 2/3rd of vagina extending into vaginal fornices and abutting right lower cervix superiorly, right paravaginal extension and mesorectal fascia. No significant enlarged lymph nodes were seen. In view of localised disease she underwent Type III Radical hysterectomy with bilateral salpingo-ophorectomy with bilateral pelvic lymphnode dissection with total vaginectomy. Histopathology s/o 2 tumour nodules, one located in the anterior vaginal cuff measuring – 5 x 5 x 3.2 cm, another located in right lateral vaginal cuff measuring 2.5 x 3 x 1.5 cm, malignant melanoma with involvement of the cervix with full thickness stromal invasion (2.8/2.8 cm,) invading perivaginal soft tissue, distance of invasive carcinoma from closest stromal margin <0.1cm (12 O’ clock), LVI, PNI – not seen, all pelvic LN free (0/25). In view of positive margin and full thickness stromal involvement, she received radiotherapy to pelvis and Inguinal region to a dose of 45 Gy/25# followed by a boost of 16 Gy/8# to the tumour bed till 01/01/16. Another case is a 40 yrs female, presented with complaints of bloody discharge per vaginum of 4 months duration. On examination, there was a large growth occupying the vagina till introitus. Cervix normal, para free. MRI Pelvis showed altered lesion involving left lateral uterine cervix and upper 2/3rd of vagina with full thickness stromal involvement with mild left parametrial, anterior and posterior paravaginal extension, measuring 2.9 x 4.5 x 5.3 cm. Few subcmlymphnodes were seen in bilateral external and internal iliac regions (L>R). Vaginal Biopsy was suggestive of Malignant Melanoma, expressing S-100, HMB 45 and SDX-10. Metastatic work up was negative. She underwent RH with total vaginectomy with bilateral PLND with RPLND. HPR showed exophytic black growth seen involving all quadrants of vagina, extending upwards into both lips of cervix – 7 x 6 x 2.5 cm, Malignant melanoma, distance of invasive carcinoma from closest margin: <0.1 cm (paravaginal soft tissue), 3/8 right Pelvic LN, ECE +, 01/9 Left pelvic LN, ECE absent, 0/6 Right common iliac LN, 0/1 Reperitoneal LN was seen. She received adjuvant radiotherapy to a dose of 50 Gy/25# to the pelvis and inguinals→ boost of 6 Gy/3# to nodal regions showing ECE & 10 Gy/5# to the primary region.
APA, Harvard, Vancouver, ISO, and other styles
7

Sakai, K., M. Nakamura, W. Yamagami, T. Chiyoda, Y. Kobayashi, H. Nishio, S. Hayashi, et al. "EP1111 Effectiveness of drainage following laparoscopic pelvic lymph node dissection." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.1153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kaur, Inderjit. "Case report of vaginal melanoma." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685370.

Full text
Abstract:
Primary malignant melanoma of vagina is a rare disease with a predilection for local recurrence, distant metastasis and short survival time. Due to the low incidence and lack of reporting in the literature, treatment choices still remain controversial. We describe 2 cases of vaginal malignant melanoma. A 42 yr old female presented with complaints of post coital and per vaginal bleed of 1 month duration. Examination findings shows growth 6 cm x 6 cm on anterior vaginal wall, another 3 x 3 cm lesion on right lateral vagianl wall. Vaginal biopsy showed malignant melanoma, S-100 and HMB-45 positive while negative for CK and LCA. MRI Whole abdomen showed altered lesion [3.8 cm (AP), 6.0 cm (TR) and 4.9 cm (CC)] in upper 2/3rd of vagina extending into vaginal fornices and abutting right lower cervix superiorly, right paravaginal extension and mesorectal fascia. No significant enlarged lymph nodes were seen. In view of localised disease she underwent Type III Radical hysterectomy with bilateral salpingo-ophorectomy with bilateral pelvic lymphnode dissection with total vaginectomy. Histopathology s/o 2 tumour nodules, one located in the anterior vaginal cuff measuring – 5 x 5 x 3.2 cm, another located in right lateral vaginal cuff measuring 2.5 x 3 x 1.5 cm, malignant melanoma with involvement of the cervix with full thickness stromal invasion (2.8/2.8 cm,) invading perivaginal soft tissue, distance of invasive carcinoma from closest stromal margin <0.1 cm (12 O’ clock), LVI, PNI – not seen, all pelvic LN free (0/25). In view of positive margin and full thickness stromal involvement, she received radiotherapy to pelvis and Inguinal region to a dose of 45 Gy/25# followed by a boost of 16 Gy/8# to the tumour bed till 01/01/16. Another case is a 40 yrs female, presented with complaints of bloody discharge per vaginum of 4 months duration. On examination, there was a large growth occupying the vagina till introitus. Cervix normal, para free. MRI Pelvis showed altered lesion involving left lateral uterine cervix and upper 2/3rd of vagina with full thickness stromal involvement with mild left parametrial, anterior and posterior paravaginal extension, measuring 2.9 x 4.5 x 5.3 cm. Few subcmlymphnodes were seen in bilateral external and internal iliac regions (L>R). Vaginal Biopsy was suggestive of Malignant Melanoma, expressing S-100, HMB 45 and SDX-10. Metastatic work up was negative. She underwent RH with total vaginectomy with bilateral PLND with RPLND. HPR showed exophytic black growth seen involving all quadrants of vagina, extending upwards into both lips of cervix – 7 x 6 x 2.5 cm, Malignant melanoma, distance of invasive carcinoma from closest margin: <0.1 cm (paravaginal soft tissue), 3/8 right Pelvic LN, ECE +, 01/9 Left pelvic LN, ECE absent, 0/6 Right common iliac LN, 0/1 Reperitoneal LN was seen. She received adjuvant radiotherapy to a dose of 50 Gy/25# to the pelvis and inguinals→ boost of 6 Gy/3# to nodal regions showing ECE & 10Gy/5# to the primary region.
APA, Harvard, Vancouver, ISO, and other styles
9

Mageed, Hisham Abdel. "2022-VA-808-ESGO Minimally invasive inguinal lymph node dissection technique." In ESGO 2022 Congress. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-esgo.931.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kato, Tomoyasu, Syoichi Kitamura, Risako Ozawa, Takashi Natsume, Erisa Fujii, Mayumi Kato, Yasuhito Tanase, Masaya Uno, and Mitsuya Ishikawa. "Outcome of therapeutic lymph node dissection for stage IIIC2 uterine cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.e27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lateral lymph node dissection"

1

Yang, Jianqiao, and Liang Shang. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Radical Gastrectomy. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cheville, Andrea L. Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2007. http://dx.doi.org/10.21236/ada485555.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cheville, Andrea L. Assesment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2008. http://dx.doi.org/10.21236/ada491730.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cheville, Andrea L. Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada433048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cheville, Andrea L. Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, March 2011. http://dx.doi.org/10.21236/ada564266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cheville, Andrea L. Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2005. http://dx.doi.org/10.21236/ada458225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cheville, Andrea L. Assessment of Lymphedema Risk Following Lymph Node Dissection and Radiation Therapy for Primary Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2006. http://dx.doi.org/10.21236/ada462808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lu, Yuanyuan, Jingping Chen, Renji Wei, Wenting Lin, Yudong Chen, Yicheng Su, Lijuan Liu, Yukun Liang, and Mulan Wei. Application of robotic surgery and traditional laparoscopic surgery in lymph node dissection for gynecological cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Deng, Chun, Zhenyu Zhang, Zhi Guo, Hengduo Qi, Yang Liu, Haimin Xiao, and Xiaojun Li. Assessment of intraoperative use of indocyanine green fluorescence imaging on the number of lymph node dissection during minimally invasive gastrectomy: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0062.

Full text
Abstract:
Review question / Objective: Whether is indocyanine green fluorescence imaging-guided lymphadenectomy feasible to improve the number of lymph node dissections during radical gastrectomy in patients with gastric cancer undergoing curative resection? Condition being studied: Gastric cancer was the sixth most common malignant tumor and the fourth leading cause of cancer-related death in the world. Radical lymphadenectomy was a standard procedure in radical gastrectomy for gastric cancer. The retrieval of more lymph nodes was beneficial for improving the accuracy of tumor staging and the long-term survival of patients with gastric cancer. Indocyanine green(ICG) near-infrared fluorescent imaging has been found to provide surgeons with effective visualization of the lymphatic anatomy. As a new surgical navigation technique, ICG near-infrared fluorescent imaging was a hot spot and had already demonstrated promising results in the localization of lymph nodes during surgery in patients with breast cancer, non–small cell lung cancer, and gastric cancer. In addition, ICG had increasingly been reported in the localization of tumor, lymph node dissection, and the evaluation of anastomotic blood supply during radical gastrectomy for gastric cancer. However, it remained unclear whether ICG fluorescence imaging would assist surgeons in performing safe and sufficient lymphadenectomy.
APA, Harvard, Vancouver, ISO, and other styles
10

Robotic cystectomy and lymph node dissection. BJUI Knowledge, January 2016. http://dx.doi.org/10.18591/bjuik.0150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Lateral lymph node dissection' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography